Analysis of the Gold Market's Recent Performance and Outlook
Since late December last year, the "Trump Trade" has driven up U.S. dollar interest rates and exchange rates. But gold didn't drop much; instead, the U.S. Dollar Index and gold prices rose together.In the short term, with the Federal Reserve's rate - cut expectations weakening and safe - haven buying cooling due to the Israel - Palestine deal, gold may face challenges. Long - term, in 2025 Q1, Trump's gradual tariff hikes could lead to re - inflation or economic slowdown, both good for gold prices. Also, U.S. fiscal issues affect the dollar's credit, and central banks' de - dollarization gold purchases make gold more likely to rise.The Impact of U.S. Dollar Interest Rates and Re - inflationThe Rebound of the Real U.S. Dollar Interest Rate Restricts Gold Prices: A strong U.S. job market in
Japan's Likely Rate Hike: A 17-Year High That Could Shake the World?
Previews on BOJ MeetingAfter the July 24 rate hike, the yen appreciated to around 140, when a large number of yen hedging trades were closed out, and the entire Japanese stock $iShares JPX-Nikkei 400 ETF(JPXN)$ and U.S. stock $SPDR S&P 500 ETF Trust(SPY)$ marketshave all seen a significant wave of pullbacks.Just past the December meeting, the Bank of Japan kept its policy rate unchanged at 0.25% at its December meeting (with one dissenting vote), with hawkish member Naoki Tamura stating that upside risks to inflation were increasing and proposing a rate hike to 0.50%.In the post-meeting press conference, Governor Ueda's statement was borderline dovish, which also caused the yen exchange rate to retreat
Qualcomm (QCOM): Bullish on Connecting the Future Beyond Smartphones
$Qualcomm(QCOM)$ is renowned for its leadership in the smartphone market, powering approximately 30% of global devices, including flagship models from Samsung, Xiaomi, and OnePlus. As smartphone growth stabilizes, Qualcomm's strategic diversification into high-growth sectors presents an exciting investment opportunity. Currently trading at $167.27 per share (as of 21 Jan 2025), the company offers a 2.03% dividend yield, with an impressive 23-year track record of dividend increases. 1. Automotive Evolution Qualcomm is transforming the automotive industry through partnerships with giants like General Motors, Hyundai, and BMW. Its Snapdragon Digital Chassis enables advanced features such as autonomous drivin
Netflix Record-Breaking Quarter: How to Maximize Profits Before the Next Big Move!
$Netflix(NFLX)$ delivered a stunning earnings report for the fourth quarter, sending its stock soaring to $995 in pre-market trading on January 22, 2025. The streaming giant exceeded expectations on both the top and bottom lines, raised its 2025 revenue forecast, and reported a record-breaking 19 million new subscribers in a single quarter, pushing its total memberships past the 300 million mark. Let’s break down the latest results, evaluate Netflix’s prospects, and outline strategic ways to position for the next potential moves in Netflix stock. Key Highlights from Netflix’s Earnings Netflix’s latest performance highlights its continued dominance in the streaming market: Record Subscriber Growth: 19 million new members added this quarter, the hig
Option Movers | NVDA, MSFT, ORCL and ARM See Bullish Sentiment; Traders Bet NFLX to $1000 This Week
Market OverviewWall Street's indexes rose on Wednesday (Jan. 22), with the benchmark S&P 500 hitting an intraday record high as investors cheered streaming video provider Netflix's quarterly report and President Donald Trump's private-sector artificial intelligence infrastructure investment plan.Regarding the options market, a total volume of 46,178,140 contracts was traded, down 5% from the previous trading day.Top 10 Option VolumesTop 10: $NVDA(NVDA)$, $TSLA(TSLA)$, $VIX(VIX)$, $AAPL(AAPL)$, $AMZN(AMZN)$, $PLTR(PLTR)$,
$Cameco(CCJ)$Santee Cooper is actively seeking proposals for the acquisition and completion of two nuclear reactors at the V.C. Summer Nuclear Station in South Carolina. The move comes amid heightened demand for electricity and a burgeoning interest in nuclear power, particularly from tech companies aiming to support AI data center expansions.Short term bullish momentum, but nuclear energy business is still too capital intensive that requires more government support and funding, with low profit compared to Natural Gas.There might be more constructions in the future as we see inventory of Uranium stocking up, and the demand of energy from AI data centers will cause a surge in energy prices.Investment cycle is lengthy for th
The S&P 500 index hits a new intraday high amid the AI boom; tech stocks lead the decline in Hong Kong's stock market. 🇺🇸 S&P 500 Index: +0.61% 📈 🇺🇸 Nasdaq: +1.28% 📈 🇪🇺 Stoxx 600 Index: +0.39% 📈 🇯🇵 Nikkei 225 Index: +1.58% 📈 🇭🇰 Hang Seng Index: -1.63% 📉 🇨🇳 CSI 300 Index: -0.93% 📉 🇸🇬 Straits Times Index: -0.37% 📉 US stocks surged, with the S&P 500 and Nasdaq rising by 0.6% and 1.3%, respectively, as investors were buoyed by Netflix's $Netflix(NFLX)$ quarterly report and President Trump's AI infrastructure investment plan. The Asia-Pacific markets declined, with Hong Kong's Hang Seng Index and China's CSI 300 Index falling by -1.6% and -0.9%, respectively, as tech stocks broadly dropped following the announ
$SoundHound AI Inc(SOUN)$ ⭐️Latest Update from SoundHound AI⭐️ SoundHound AI, a leading provider of conversational AI technology, has announced a strategic alliance with Rekor Systems, a global provider of AI-powered vehicle intelligence solutions. This partnership aims to integrate SoundHound's voice and conversational AI capabilities with Rekor's automatic license plate recognition (ALPR) systems, transforming how law enforcement and emergency responders operate. By combining SoundHound's advanced voice AI with Rekor's cutting-edge vehicle recognition technology, this collaboration will enable hands-free operation of critical vehicle systems. This includes features such as voice-controlled management
$Roundhill N-100 0DTE Covered Call Strategy ETF(QDTE)$ I have further increased my position in this following counter for dividend . At 33% dividend yield implies a yield of 23.1% dividend yield after tax . Hold it for 5 years and the counter Is technically free . As this counters sells 0DTE call option on nasdaq index , this counter is highly risky . My take is that the greater the volitaility , the greater the premium .
EXCLUSIVE DEALS & PRIVILEGES WHEN YOU USE TIGER BOSS DEBIT CARD!
Hey Tigers!We’ve got some exciting news to kick off the Year of the Snake!Partnership Rewards and PrivilegesThis year, we’ll be connecting with familiar brands to offer you exclusive partnership rewards and privileges, enhancing your benefits when using our Tiger BOSS Debit Card.In addition to earning 1.0% fractional shares* cashback, you’ll also enjoy discounts and free gifts! It’s that easy! Just flash and pay with your Tiger BOSS Debit Card to unlock amazing deals. Prefer shopping online? No problem! Use the promo code in the terms and conditions at checkout and pay with your Tiger BOSS Debit Card to score exclusive discounts! To find out the available deals and privileges, simply head over to our Partnership Deals & Privileges page
$Nike(NKE)$ Nike Inc. (ticker: NKE) is currently trading at $71 per share2 day ago. Year-to-date, the stock has dropped nearly 6.5%, and over the past year, it is down about 30%. This marks its lowest point on a 5-year chart since the pandemic in 2020, when it hit a low of approximately $67. Over the last five years, the stock is up roughly 5%, but it remains well below its historical highs. The key question now is whether Nike can recover to those previous levels. To analyze this, I'll be using my automated stock valuation spreadsheet. This includes valuation methods such as the discounted cash flow (DCF) model, comparable company analysis, dividend discount model, and the Benjamin Graham intrinsic value formula. We'll input Nike’s ticker symbol (
$Tempus AI(TEM)$ Precision Medicine Leadership• Unmatched Data Scale: Tempus AI boasts over 50 petabytes of clinical & molecular data -- an unrivaled foundation in precision medicine.• Broad Adoption & Impact: Trusted by 50% of top U.S. cancer centers & processing 30K genomic tests monthly at a 98% accuracy rate -- Tempus has supported over 3M patients with personalized care.• Pharma Reliance: Over 80% of the world’s top 20 pharmaceutical companies depend on Tempus AI for breakthroughs in drug discovery, clinical trials & real-world evidence.AI-Driven Insights Beyond Oncology• Broader Applications: Tempus is actively involved in 200+ projects across cardiology & neurology -- significantly expanding its TAM. • Rare Disease Innova